General Information of the Compound
| Compound ID |
CP0538107
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-amino-N-[6-methoxy-2-(4-methyl-1,4-diazepan-1-yl)-4-[(1-methylpiperidin-4-yl)amino]quinazolin-7-yl]pentanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H42N8O2
|
||||||||||||||||||
| Molecular Weight |
498.676
|
||||||||||||||||||
| Canonical SMILES |
COc1cc2c(NC3CCN(C)CC3)nc(nc2cc1NC(=O)CCCCN)N1CCCN(C)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H42N8O2/c1-32-11-6-12-34(16-15-32)26-30-21-18-22(29-24(35)7-4-5-10-27)23(36-3)17-20(21)25(31-26)28-19-8-13-33(2)14-9-19/h17-19H,4-16,27H2,1-3H3,(H,29,35)(H,28,30,31)
Show/Hide
|
||||||||||||||||||
| InChIKey |
SFOCRSFKWQNGAT-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02221, Histone-lysine N-methyltransferase EHMT1
Protein ID: PT01566, Histone-lysine N-methyltransferase EHMT2